エアロシンを生成するエロモナスの変種は,潰瘍性大腸炎の感受性を促進する
Zhihui Jiang1, Ye Wang1, Jianfeng Gong2
1State Key Laboratory of Pharmaceutical Biotechnology, National Resource Center for Mutant Mice, Department of Gastroenterology of Nanjing Drum Tower Hospital, and Suqian Scientific Research Institute, Medical School of Nanjing University, Nanjing, China.
Science (New York, N.Y.)
|November 20, 2025
まとめ
マクロファージ有毒細菌 (MTB) と呼ばれる新しいAeromonasバクテリアの変種は,潰瘍性大腸炎 (UC) の患者で発見されました. このMTBはマクロファージの死を引き起こし,マウスの大腸炎を引き起こし,炎症性腸疾患の新たな治療目標を示唆しています.
科学分野:
- 胃腸内科
- 免疫学
- 微生物学
背景:
- 潰瘍性大腸炎 (UC) は,病因がよくわかっていない慢性炎症性腸疾患です.
- マクロファージはUCの初期段階の結腸組織で枯渇し,明らかに上皮の炎症が先行する.
研究 の 目的:
- 細菌の毒素がUCの病原化に 果たす役割を調査する
- UCにおけるマクロファージ機能障害に寄与する特定の細菌と毒素を特定する.
主な方法:
- UC患者の便サンプルから細菌株を分離する.
- マクロファージの生存能力に関する細菌毒素のインビトロ試験
- 単離された細菌株を用いてマウスの大腸炎を誘導する.
- 細菌毒素に対する抗体を用いた治療効果の評価
主要な成果:
- マクロファージ有毒細菌 (MTB) と呼ばれる特定のAeromonas変種がUC患者から隔離されました.
- MTBによって分泌されるアエロリシンはマクロファージの死を引き起こす.
- マウスのMTBコロニーは大腸炎を誘発し,それは抗アエロリン抗体によって緩和された.
- UC患者は,健康な対照群と比較して,Aeromonasのより高い流行を示した.
結論:
- アエロモナス菌とそのアエロリシン毒素は,マクロファージを損なうことでUCの病原化に重要な役割を果たします.
- アエロリシンを標的とする治療は,潰瘍性大腸炎の潜在的治療戦略です.
関連する概念動画
01:29Drugs for Treatment of Ulcerative Colitis in IBD
435
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
435
01:28Gene Regulation in Microbial Communities: Quorum Sensing
479
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
479
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
876
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
876
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
01:30Peptic Ulcer Disease I: Introduction
719
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
719
01:28Peptic Ulcer Disease II: Pathophysiology
1.9K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.9K